-
UPCC 02818: A Phase I/IB Study of Avelumab in Combination with Gemcitabine for Advanced Renal Cell Carcinoma with Sarcomatoid ...
This study is being done because doctors are trying to develop better methods for treating kidney cancer that has spread ...
-
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at ...
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your ... -
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA ...
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney ... -
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects with Primary Focal ...
Primary FSGS is a progressive disease that causes the kidneys to scar, to leak protein into the urine and may ...
-
UPCC 05818: A phase I/II study to evaluate the safety pharmacodynamics and efficacy of atezolizumab in combination with entinostat ...
The purpose of this study is to identify the best dose of entinostat when combined with bevacizumab and atezolizumab and ...
-
The Nephrotic Syndrome Study Network
The Nephrotic Syndrome Study Network (NEPTUNE) is a multi-disciplinary, multi-center longitudinal observational study. The main purpose of this study is ...
-
Randomized Controlled Trial to Evaluate the Effect of Lost Wage Reimbursement to Potential Kidney Donors on Living Donation Rates
This study is being done to learn if offering to reimburse kidney donors for wages they would lose by being ...
-
REBOOT- Combination of Belimumab with Rituximab for Primary MN
The main purpose of this study is to learn if the combination of belimumab and rituximabtreatment is more effective ...
Showing - of trials